Skip to content

New results from PIVOTAL trial

New results from PIVOTAL trial 05 July 2022 The pioneering PIVOTAL trial, one of the largest renal clinical trials undertaken exclusively in the UK, and co-ordinated by Kidney Research UK has delivered a new set of results.    The PIVOTAL trial investigated the use of intravenous iron to treat anaemia in dialysis patients, focusing on patient…

Read More

New treatment recommended for kidney patients with anaemia

New treatment recommended for kidney patients with anaemia 21 June 2022 The National Institute for Health and Care Excellence (NICE) has recommended roxadustat for the treatment of anaemia in adult chronic kidney disease (CKD) patients. The new first of its kind medication (brand name Evrenzo) will offer a simplified and more tolerable treatment. The exciting…

Read More

A pivotal result for people on dialysis

A pivotal result for people on dialysis In 2019, our ‘PIVOTAL’ study concluded, publishing evidence around the safest way to treat anaemia in dialysis patients. We were delighted to have delivered one of the largest renal clinical trials to have taken place in the UK. Anaemia is a common problem in dialysis, for which patients…

Read More
Scroll To Top